"Prospective Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
| Descriptor ID |
D011446
|
| MeSH Number(s) |
E05.318.760.500.750.625 N05.715.360.775.175.250.630 N06.850.520.450.500.750.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prospective Studies".
Below are MeSH descriptors whose meaning is more specific than "Prospective Studies".
This graph shows the total number of publications written about "Prospective Studies" by people in this website by year, and whether "Prospective Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 7 | 7 |
| 1997 | 0 | 12 | 12 |
| 1998 | 0 | 12 | 12 |
| 1999 | 0 | 5 | 5 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 13 | 13 |
| 2002 | 0 | 13 | 13 |
| 2003 | 0 | 14 | 14 |
| 2004 | 0 | 19 | 19 |
| 2005 | 0 | 17 | 17 |
| 2006 | 0 | 23 | 23 |
| 2007 | 0 | 25 | 25 |
| 2008 | 0 | 24 | 24 |
| 2009 | 0 | 17 | 17 |
| 2010 | 0 | 30 | 30 |
| 2011 | 0 | 30 | 30 |
| 2012 | 0 | 50 | 50 |
| 2013 | 0 | 44 | 44 |
| 2014 | 0 | 50 | 50 |
| 2015 | 0 | 57 | 57 |
| 2016 | 0 | 73 | 73 |
| 2017 | 0 | 77 | 77 |
| 2018 | 0 | 64 | 64 |
| 2019 | 0 | 77 | 77 |
| 2020 | 0 | 78 | 78 |
| 2021 | 0 | 60 | 60 |
| 2022 | 0 | 39 | 39 |
| 2023 | 0 | 25 | 25 |
| 2024 | 0 | 22 | 22 |
| 2025 | 0 | 13 | 13 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prospective Studies" by people in Profiles.
-
Neoadjuvant/adjuvant relugolix and enzalutamide for the treatment of high-risk locally advanced prostate cancer: study protocol of the RENAPCA phase Ib trial. BMJ Open. 2026 Apr 24; 16(4):e112623.
-
Physical Activity in Osteosarcoma Patients During and Post Therapy: A Single Site Prospective Observational Study. Cancer Med. 2026 Mar; 15(3):e71674.
-
Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. JACC Cardiovasc Imaging. 2026 Apr; 19(4):516-534.
-
Validity of Spectral-Domain Optical Coherence Tomography Angiography for Detection of Retinal Vasculitis. Ophthalmic Surg Lasers Imaging Retina. 2026 Mar; 57(3):160-167.
-
Pregnancy and breastfeeding are associated with less later-life cognitive decline in a longitudinal, prospective cohort. Alzheimers Dement. 2026 Jan; 22(1):e71072.
-
Real-Time Prediction of Irreversible Lesion Size During Pulsed Field Ablation: Prospective Validation of a Novel Ablation Index Based on Contact Force and Number of Applications in a Swine Beating Heart Model. Circ Arrhythm Electrophysiol. 2025 Dec; 18(12):e013911.
-
The kynurenine pathway in pediatric "mild-to-moderate" traumatic brain injury: translational insights from a prospective human study and a large-animal model. Brain Behav Immun. 2026 Jan; 131:106189.
-
Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study. Urol Oncol. 2026 Jan; 44(1):65.e13-65.e20.
-
Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease. Metabolomics. 2025 Oct 25; 21(6):153.
-
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263). Gynecol Oncol. 2025 Nov; 202:102-109.